DK327285A - Substituerede amider, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende disse forbindelser - Google Patents

Substituerede amider, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende disse forbindelser Download PDF

Info

Publication number
DK327285A
DK327285A DK327285A DK327285A DK327285A DK 327285 A DK327285 A DK 327285A DK 327285 A DK327285 A DK 327285A DK 327285 A DK327285 A DK 327285A DK 327285 A DK327285 A DK 327285A
Authority
DK
Denmark
Prior art keywords
radical
alkyloxy
substituted
alkyl
het
Prior art date
Application number
DK327285A
Other languages
English (en)
Other versions
DK327285D0 (da
Inventor
Claude Cotrel
Claude Guyon
Gerard Roussel
Gerard Taurand
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of DK327285D0 publication Critical patent/DK327285D0/da
Publication of DK327285A publication Critical patent/DK327285A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
  • Cephalosporin Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Quinoline Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK327285A 1984-07-19 1985-07-18 Substituerede amider, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende disse forbindelser DK327285A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8411442A FR2567887B1 (fr) 1984-07-19 1984-07-19 Nouveaux amides substitues, leur preparation et les medicaments qui les contiennent

Publications (2)

Publication Number Publication Date
DK327285D0 DK327285D0 (da) 1985-07-18
DK327285A true DK327285A (da) 1986-01-20

Family

ID=9306273

Family Applications (1)

Application Number Title Priority Date Filing Date
DK327285A DK327285A (da) 1984-07-19 1985-07-18 Substituerede amider, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende disse forbindelser

Country Status (27)

Country Link
US (1) US4642308A (da)
EP (1) EP0172083B1 (da)
JP (1) JPS6163656A (da)
KR (1) KR860001100A (da)
AT (1) ATE33652T1 (da)
AU (1) AU572672B2 (da)
CA (1) CA1224787A (da)
CS (1) CS253730B2 (da)
DD (1) DD240011A5 (da)
DE (1) DE3562250D1 (da)
DK (1) DK327285A (da)
ES (1) ES8604584A1 (da)
FI (1) FI79313C (da)
FR (1) FR2567887B1 (da)
GR (1) GR851774B (da)
HU (1) HU199802B (da)
IL (1) IL75817A (da)
MA (1) MA20487A1 (da)
NO (1) NO161673C (da)
NZ (1) NZ212764A (da)
OA (1) OA08069A (da)
PH (1) PH21301A (da)
PL (1) PL145331B1 (da)
PT (1) PT80840B (da)
SU (1) SU1417797A3 (da)
YU (1) YU118785A (da)
ZA (1) ZA855409B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4720500A (en) * 1985-07-11 1988-01-19 Rhone-Poulenc Sante N-1,8-naphthyridin-2-yl amides useful as immunostimulants
FR2592882B2 (fr) * 1986-01-16 1988-03-11 Rhone Poulenc Sante Nouveaux amides substitues, leur preparation et les medicaments qui les contiennent
US4753941A (en) * 1986-01-16 1988-06-28 Rhone-Poulenc Sante Amides based on certain 1,8-naphtyridine-2-amines useful as anxiolytics
US5197518A (en) * 1991-06-27 1993-03-30 Double Containment Systems Centering support assembly for double containment pipe systems
GB9711257D0 (en) * 1997-05-30 1997-07-30 Smithkline Beecham Plc Novel compounds
JP2002537396A (ja) * 1999-02-22 2002-11-05 バイオケム ファーマ インコーポレイテッド 抗ウィルス活性を有する［１，８］ナフチリジン誘導体
WO2005046683A1 (en) * 2003-10-07 2005-05-26 Renovis, Inc. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
US20080300243A1 (en) * 2005-02-28 2008-12-04 Kelly Michael G Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
US7576099B2 (en) 2005-02-28 2009-08-18 Renovis, Inc. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
WO2013090725A1 (en) * 2011-12-15 2013-06-20 Philadelphia Health & Education Corporation NOVEL PI3K p110 INHIBITORS AND METHODS OF USE THEREOF
CN105646487B (zh) * 2016-03-15 2017-12-05 红河学院 一类溴代1,8‑萘啶衍生物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB661515A (en) * 1948-08-31 1951-11-21 Cilag Ltd Process for the production of naphthyridine derivatives
FR1006725A (fr) * 1948-08-31 1952-04-28 Cilag Spa Nouveaux dérivés de la naphtyridine et procédé pour leur préparation
US3389142A (en) * 1966-09-29 1968-06-18 Bristol Myers Co Esters of 2-substituted 1, 2-dihydroquinoline-nu-carboxylic acids and thione acids
US3576809A (en) * 1968-05-06 1971-04-27 Miles Lab 2-substituted derivatives of 6-methoxyquinoline
US3624097A (en) * 1969-07-22 1971-11-30 Warner Lambert Co N-pyridine 5-aminooxazoles
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use

Also Published As

Publication number Publication date
NZ212764A (en) 1988-05-30
CS253730B2 (en) 1987-12-17
MA20487A1 (fr) 1986-04-01
AU4509085A (en) 1986-01-23
EP0172083B1 (fr) 1988-04-20
ES8604584A1 (es) 1986-02-01
PH21301A (en) 1987-09-28
IL75817A (en) 1988-06-30
PL254570A1 (en) 1986-10-21
PL145331B1 (en) 1988-09-30
ZA855409B (en) 1986-04-30
FI852821L (fi) 1986-01-20
NO161673C (no) 1989-09-13
NO161673B (no) 1989-06-05
ES545336A0 (es) 1986-02-01
PT80840A (fr) 1985-08-01
DD240011A5 (de) 1986-10-15
NO852877L (no) 1986-01-20
DK327285D0 (da) 1985-07-18
US4642308A (en) 1987-02-10
PT80840B (pt) 1988-02-17
CA1224787A (fr) 1987-07-28
IL75817A0 (en) 1985-11-29
SU1417797A3 (ru) 1988-08-15
FI852821A0 (fi) 1985-07-18
HU199802B (en) 1990-03-28
GR851774B (da) 1985-11-26
YU118785A (en) 1988-10-31
FR2567887B1 (fr) 1986-12-19
ATE33652T1 (de) 1988-05-15
KR860001100A (ko) 1986-02-22
OA08069A (fr) 1987-03-31
JPS6163656A (ja) 1986-04-01
HUT40799A (en) 1987-02-27
AU572672B2 (en) 1988-05-12
FI79313B (fi) 1989-08-31
FI79313C (fi) 1989-12-11
FR2567887A1 (fr) 1986-01-24
EP0172083A1 (fr) 1986-02-19
DE3562250D1 (en) 1988-05-26

Similar Documents

Publication Publication Date Title
DK327285D0 (da) Substituerede amider, fremgangsmaade til deres fremstilling og farmaceutiske praeparater indeholdende disse forbindelser
DK280789A (da) Komplekser af beta-cyclodextrin med salte af ibuprofen, fremgangsmaade til fremstilling af saadanne komplekser og farmaceutiske midler indeholdende disse
ATE21900T1 (de) Pyrimidinonderivate und diese enthaltende pharmazeutische zusammenstellungen.
DK359184A (da) Pyrimidonforbindelser
DK19787A (da) Substituerede amider, deres fremstilling og farmaceutiske praeparater indeholdende disse forbindelser
FR2660313B1 (fr) Nouveau sulfonyl-phenyl-betha-d-thioxylosides, leur procede de preparation et leur utilisation en therapeutique.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment